Ontology type: schema:ScholarlyArticle Open Access: True
2013-02
AUTHORSYukihiro Miyazaki, Yuichiro Nawa, Masao Miyagawa, Sumiko Kohashi, Koichi Nakase, Masaki Yasukawa, Masamichi Hara
ABSTRACTThe treatment of patients with diffuse large B cell lymphoma (DLBCL) would be greatly facilitated with a rapid method for determining prognosis that can be performed more easily and earlier than cytological or specific pathological examinations. It has been suggested that newly diagnosed patients with DLBCL who have low maximum standard uptake value (SUV(max)) on (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) are more likely to be successfully treated and remain in remission compared with patients with high SUV(max), but this concept has been poorly studied. We retrospectively analyzed 50 patients with de novo DLBCL to evaluate the relationship between the SUV(max) and disease progression. For patients with low SUV(max) (n = 10) and high SUV(max) (n = 40) (P = 0.255), respectively, the 3-year overall survival rates were 90 and 72 %, and the progression-free survival (PFS) rates were 90 and 39 % (P = 0.012). By multivariate analysis, the revised International Prognostics Index (R-IPI) and SUV(max) at diagnosis were shown to predict longer PFS. The 3-year PFS for patients with low SUV(max) classified into the good prognosis group by R-IPI was 100 vs. 62 % for those with high SUV(max) (P = 0.161), and patients with low SUV(max) classified into the poor prognosis group by R-IPI was 80 vs. 18 % for those with high SUV(max) (P = 0.050). We conclude that the SUV(max) on FDG-PET for newly diagnosed patients with DLBCL is an important predictor of disease progression, especially for patients with poor prognosis by R-IPI. More... »
PAGES239-244
http://scigraph.springernature.com/pub.10.1007/s00277-012-1602-3
DOIhttp://dx.doi.org/10.1007/s00277-012-1602-3
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1016010275
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/23079891
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adult",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Age Factors",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged, 80 and over",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antibodies, Monoclonal, Murine-Derived",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antineoplastic Combined Chemotherapy Protocols",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Combined Modality Therapy",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cyclophosphamide",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Disease-Free Survival",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Doxorubicin",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Fluorine Radioisotopes",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Fluorodeoxyglucose F18",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Hematopoietic Stem Cell Transplantation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Kaplan-Meier Estimate",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Lymphoma, Large B-Cell, Diffuse",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Patient Selection",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Positron-Emission Tomography",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Prednisolone",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Prognosis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Proportional Hazards Models",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Radiopharmaceuticals",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Retrospective Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Rituximab",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Treatment Outcome",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Vincristine",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Ehime Prefectural Central Hospital",
"id": "https://www.grid.ac/institutes/grid.414413.7",
"name": [
"Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Shitsukawa, 791-0295, Toon, Ehime, Japan",
"Division of Hematology, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan"
],
"type": "Organization"
},
"familyName": "Miyazaki",
"givenName": "Yukihiro",
"id": "sg:person.01002012476.64",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002012476.64"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ehime Prefectural Central Hospital",
"id": "https://www.grid.ac/institutes/grid.414413.7",
"name": [
"Division of Hematology, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan"
],
"type": "Organization"
},
"familyName": "Nawa",
"givenName": "Yuichiro",
"id": "sg:person.01235232263.62",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235232263.62"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ehime Prefectural Central Hospital",
"id": "https://www.grid.ac/institutes/grid.414413.7",
"name": [
"Division of Radiology, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan"
],
"type": "Organization"
},
"familyName": "Miyagawa",
"givenName": "Masao",
"id": "sg:person.01076114534.40",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076114534.40"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ehime Prefectural Central Hospital",
"id": "https://www.grid.ac/institutes/grid.414413.7",
"name": [
"Division of Hematology, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan"
],
"type": "Organization"
},
"familyName": "Kohashi",
"givenName": "Sumiko",
"id": "sg:person.01070340147.42",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070340147.42"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ehime Prefectural Central Hospital",
"id": "https://www.grid.ac/institutes/grid.414413.7",
"name": [
"Division of Hematology, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan"
],
"type": "Organization"
},
"familyName": "Nakase",
"givenName": "Koichi",
"id": "sg:person.01174736411.20",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174736411.20"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ehime University",
"id": "https://www.grid.ac/institutes/grid.255464.4",
"name": [
"Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Shitsukawa, 791-0295, Toon, Ehime, Japan"
],
"type": "Organization"
},
"familyName": "Yasukawa",
"givenName": "Masaki",
"id": "sg:person.0730073225.12",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730073225.12"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ehime Prefectural Central Hospital",
"id": "https://www.grid.ac/institutes/grid.414413.7",
"name": [
"Division of Hematology, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan"
],
"type": "Organization"
},
"familyName": "Hara",
"givenName": "Masamichi",
"id": "sg:person.0702377030.82",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702377030.82"
],
"type": "Person"
}
],
"citation": [
{
"id": "https://doi.org/10.1093/annonc/mdn392",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1002958217"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s12185-011-0822-y",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1004034909",
"https://doi.org/10.1007/s12185-011-0822-y"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s12185-011-0822-y",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1004034909",
"https://doi.org/10.1007/s12185-011-0822-y"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1600-0609.2010.01467.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1006085010"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejm199309303291402",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1013554742"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.ctrv.2007.02.002",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1020576240"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2006.08.2305",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1020848737"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s1470-2045(11)70235-2",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1021792870"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2003-06-2095",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022035062"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3109/10428190903440953",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1024334269"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2003-05-1545",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1026049587"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood.v99.3.815",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1027088442"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2010-03-276246",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031111650"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2006-08-038257",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1036676724"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2006.09.2403",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1045509899"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s1470-2045(08)70002-0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1047262140"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejm199512073332305",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1048188294"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2010.28.1618",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1049306116"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2007-06-097238",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1050417265"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2008-06-155820",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1050529744"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2000.18.16.3025",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1074684756"
],
"type": "CreativeWork"
}
],
"datePublished": "2013-02",
"datePublishedReg": "2013-02-01",
"description": "The treatment of patients with diffuse large B cell lymphoma (DLBCL) would be greatly facilitated with a rapid method for determining prognosis that can be performed more easily and earlier than cytological or specific pathological examinations. It has been suggested that newly diagnosed patients with DLBCL who have low maximum standard uptake value (SUV(max)) on (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) are more likely to be successfully treated and remain in remission compared with patients with high SUV(max), but this concept has been poorly studied. We retrospectively analyzed 50 patients with de novo DLBCL to evaluate the relationship between the SUV(max) and disease progression. For patients with low SUV(max) (n\u2009=\u200910) and high SUV(max) (n\u2009=\u200940) (P\u2009=\u20090.255), respectively, the 3-year overall survival rates were 90 and 72\u00a0%, and the progression-free survival (PFS) rates were 90 and 39\u00a0% (P\u2009=\u20090.012). By multivariate analysis, the revised International Prognostics Index (R-IPI) and SUV(max) at diagnosis were shown to predict longer PFS. The 3-year PFS for patients with low SUV(max) classified into the good prognosis group by R-IPI was 100 vs. 62\u00a0% for those with high SUV(max) (P\u2009=\u20090.161), and patients with low SUV(max) classified into the poor prognosis group by R-IPI was 80 vs. 18\u00a0% for those with high SUV(max) (P\u2009=\u20090.050). We conclude that the SUV(max) on FDG-PET for newly diagnosed patients with DLBCL is an important predictor of disease progression, especially for patients with poor prognosis by R-IPI.",
"genre": "research_article",
"id": "sg:pub.10.1007/s00277-012-1602-3",
"inLanguage": [
"en"
],
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1018247",
"issn": [
"1269-3286",
"1279-8509"
],
"name": "Annals of Hematology",
"type": "Periodical"
},
{
"issueNumber": "2",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "92"
}
],
"name": "Maximum standard uptake value of 18F-fluorodeoxyglucose positron emission tomography is a prognostic factor for progression-free survival of newly diagnosed patients with diffuse large B cell lymphoma",
"pagination": "239-244",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"4c4919d5ae29fa07f5de7f2edb167c549eea3316563238abc4e9c3cc55d5f008"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"23079891"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"9107334"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s00277-012-1602-3"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1016010275"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s00277-012-1602-3",
"https://app.dimensions.ai/details/publication/pub.1016010275"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-10T14:54",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8663_00000487.jsonl",
"type": "ScholarlyArticle",
"url": "http://link.springer.com/10.1007/s00277-012-1602-3"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-012-1602-3'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-012-1602-3'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-012-1602-3'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-012-1602-3'
This table displays all metadata directly associated to this object as RDF triples.
293 TRIPLES
21 PREDICATES
78 URIs
50 LITERALS
38 BLANK NODES